Cargando…

Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease

Detalles Bibliográficos
Autores principales: Liu, Yang, Guo, Yubo, An, Sai, Kuang, Yuyang, He, Xi, Ma, Haojun, Li, Jianfeng, Lu, Jing, Zhang, Ning, Jiang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765454/
http://dx.doi.org/10.1371/annotation/5f08fe1e-8868-421c-92ea-1a4aa987d11f
_version_ 1782283313093804032
author Liu, Yang
Guo, Yubo
An, Sai
Kuang, Yuyang
He, Xi
Ma, Haojun
Li, Jianfeng
Lu, Jing
Zhang, Ning
Jiang, Chen
author_facet Liu, Yang
Guo, Yubo
An, Sai
Kuang, Yuyang
He, Xi
Ma, Haojun
Li, Jianfeng
Lu, Jing
Zhang, Ning
Jiang, Chen
author_sort Liu, Yang
collection PubMed
description
format Online
Article
Text
id pubmed-3765454
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37654542013-09-13 Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease Liu, Yang Guo, Yubo An, Sai Kuang, Yuyang He, Xi Ma, Haojun Li, Jianfeng Lu, Jing Zhang, Ning Jiang, Chen PLoS One Correction Public Library of Science 2013-09-04 /pmc/articles/PMC3765454/ http://dx.doi.org/10.1371/annotation/5f08fe1e-8868-421c-92ea-1a4aa987d11f Text en © 2013 Public Library of Science http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Liu, Yang
Guo, Yubo
An, Sai
Kuang, Yuyang
He, Xi
Ma, Haojun
Li, Jianfeng
Lu, Jing
Zhang, Ning
Jiang, Chen
Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
title Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
title_full Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
title_fullStr Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
title_full_unstemmed Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
title_short Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
title_sort correction: targeting caspase-3 as dual therapeutic benefits by rnai facilitating brain-targeted nanoparticles in a rat model of parkinson’s disease
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765454/
http://dx.doi.org/10.1371/annotation/5f08fe1e-8868-421c-92ea-1a4aa987d11f
work_keys_str_mv AT liuyang correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT guoyubo correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT ansai correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT kuangyuyang correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT hexi correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT mahaojun correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT lijianfeng correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT lujing correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT zhangning correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease
AT jiangchen correctiontargetingcaspase3asdualtherapeuticbenefitsbyrnaifacilitatingbraintargetednanoparticlesinaratmodelofparkinsonsdisease